Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation

Zhen Guo1, Lin Sun1, Bailing Li2

  • 1Department of Cardiovascular Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

Insights

COVID-19 patients on extracorporeal membrane oxygenation (ECMO) often experience hypercoagulability, leading to oxygenator thrombosis and bleeding complications. Current evidence does not support more aggressive anticoagulation strategies for these patients.

Area of Science:

  • Critical Care Medicine
  • Hematology
  • Infectious Diseases

Background:

  • Severe coronavirus disease 2019 (COVID-19) can necessitate extracorporeal membrane oxygenation (ECMO) for respiratory support.
  • Coagulation abnormalities are frequently observed in COVID-19 patients, posing challenges for anticoagulation management during ECMO.

Purpose of the Study:

  • To investigate the specific coagulation characteristics and anticoagulation management strategies in COVID-19 patients undergoing venovenous ECMO.
  • To identify the incidence of bleeding and thrombotic complications in this patient population.

Main Methods:

  • A retrospective observational study was conducted at a single center.
  • Data from laboratory-confirmed severe COVID-19 patients receiving venovenous ECMO between January and May 2020 were analyzed.
  • Anticoagulation management, monitoring, bleeding complications, and thrombotic events were assessed.

Main Results:

  • Eight out of 667 COVID-19 patients required venovenous ECMO, with elevated D-dimer levels noted before and during support.
  • ECMO circuit packs were replaced 13 times due to coagulation-related complications.
  • Common complications included oxygenator thrombosis (7/8), various hemorrhages (tracheal, oronasal, thoracic, puncture sites, cannulation sites).

Conclusions:

  • COVID-19 patients on ECMO exhibit common hypercoagulability and secondary hyperfibrinolysis.
  • These coagulation derangements may increase the risk of thrombotic events and oxygenator failure.
  • Insufficient evidence currently exists to advocate for more aggressive anticoagulation protocols in this cohort.
Abstract

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
186
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
170
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
147
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
166
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132